CALECO PHARMA CORP. — Form D
CALECO PHARMA CORP. of Long Valley, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-01. The offering totals $81K, of which $81K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-03-01
- Form: D
- Accession: 0001284834-10-000015
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $81K
- Amount sold: $81K
- Investors: 1
- Date of first sale: 2010-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-135368
Issuer
- Name: CALECO PHARMA CORP.
- CIK: 0001312402
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2004
- Address: 59 East Mill Road, Building 4, Suite 201, Long Valley, NJ, 07853
- Phone: 908-752-4240
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Luc Vanhal | Executive Officer | Austin, TX |
| Francisco Javier Benedi Garcia | Director | Malaga, U3 |
| John Boschert | Director | Planta Baja, R1 |
| John Boschert | Executive Officer | Planta Baja, R1 |
| Rolf G Horchler | Promoter | Moenchengladbach, 2M |
| Rudolf Javier Mauer | Promoter | Hanover, 2M |
| Perry G Augustson | Promoter | Surrey, A1 |
| James A Sandino | Director | Sherman Oaks, CA |
Other filings by this issuer (5)
More